Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Department of Medicine, Universidade Nove de Julho, São Paulo, SP, Brazil.
Neurosurg Rev. 2024 Aug 1;47(1):393. doi: 10.1007/s10143-024-02596-6.
Spontaneous intracerebral hemorrhage (ICH) represents a critical and potentially devastating medical event resulting from the rupture of intracerebral vessels. Patients afflicted with ICH face an increased risk of venous thromboembolism (VTE) due to factors such as immobility. However, determining the ideal timing for initiating venous thromboembolism thromboprophylaxis (TP) remains uncertain, as it may carry the potential risk of exacerbating hematoma expansion. Thus, our objective was to ascertain the optimal timing for initiating TP following ICH through a comprehensive systematic review and meta-analysis.This systematic review and meta-analysis were performed following the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines, considering outcomes based on the time of intervention: Ultra early (UEPT) < 24 h, Early (EPT) < 48 h, Late (LPT) > 48 h to perform an analysis on hematoma expansion and mortality.Of 2.777 Hematoma expansion was not more frequent in the 440 patients receiving UEPT/EPT (n = 440) versus 565 receiving LPT (Odds ratio (OR) 0.94 (95% CI; 0.62 to 1.43; I = 0%)). Similarly, mortality was not lower in the 293 received UEPT or EPT versus 477 receiving LPT (OR 0.63 (95% CI; 0.39 to 1.0; I = 0%).This study, through a systematic review and meta-analysis, conclusively found no difference in intracranial hematoma expansion and/or increased mortality between the use of heparin in the early thromboprophylaxis (< 48 h) group compared to the late thromboprophylaxis (> 48 h) group. Implementing this approach in the management of spontaneous cerebral hemorrhage could facilitate progress towards more optimal care protocols.
自发性脑出血 (ICH) 是一种严重且潜在破坏性的医疗事件,由脑内血管破裂引起。由于活动受限等因素,ICH 患者发生静脉血栓栓塞症 (VTE) 的风险增加。然而,确定开始静脉血栓栓塞症预防治疗 (TP) 的理想时机仍不确定,因为这可能会增加血肿扩大的风险。因此,我们的目标是通过全面的系统评价和荟萃分析来确定 ICH 后开始 TP 的最佳时机。
本系统评价和荟萃分析遵循 Cochrane 协作组织和系统评价和荟萃分析的 Preferred Reporting Items (PRISMA) 声明指南,根据干预时间考虑结局:超早期 (UEPT) < 24 小时、早期 (EPT) < 48 小时、晚期 (LPT) > 48 小时,以分析血肿扩大和死亡率。
在接受 UEPT/EPT 的 440 例患者 (n = 440) 与接受 LPT 的 565 例患者 (比值比 (OR) 0.94 (95% CI;0.62 至 1.43;I = 0%) 中,血肿扩大并不更常见。同样,在接受 UEPT 或 EPT 的 293 例患者与接受 LPT 的 477 例患者中,死亡率也没有降低 (OR 0.63 (95% CI;0.39 至 1.0;I = 0%)。
本研究通过系统评价和荟萃分析发现,在早期 ( < 48 小时) 与晚期 ( > 48 小时) 预防性使用肝素治疗中,颅内血肿扩大和/或死亡率无差异。在自发性脑溢血的治疗中采用这种方法,有助于制定更优化的护理方案。